Evoke (LON:EVOK) Shares Down 10% – Should You Sell?

Evoke plc (LON:EVOKGet Free Report) shares traded down 10% during mid-day trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).

Analysts Set New Price Targets

Several analysts recently commented on EVOK shares. Berenberg Bank cut their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.

View Our Latest Analysis on EVOK

Evoke Price Performance

The firm has a market cap of £224.78 million, a price-to-earnings ratio of -1.26 and a beta of 0.84. The stock’s fifty day moving average price is GBX 68.88 and its 200-day moving average price is GBX 63.49.

Evoke (LON:EVOKGet Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, equities research analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.

Insider Activity at Evoke

In related news, insider Andrea Gisle Joosen bought 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by insiders.

Evoke Company Profile

(Get Free Report)

Featured Articles

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.